PEOPLE - AtherGenics (US) makes appointment:
This article was originally published in Clinica
Executive Summary
AtheroGenics, a US developer of diagnostics for atherosclerosis, has elected Dr William Scott, CEO and president of Physiome Sciences, to its board of directors.